Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2015 Oct 9;233(2):225–233. doi: 10.1007/s00213-015-4098-4

Table 1.

Demographic information and comparisons for subjects given placebo (n=25), amphetamine 10 mg (n=18), and amphetamine 20 mg (n=23). Values are means (standard deviations) unless otherwise specified.

Placebo Amphetamine
10 mg
Amphetamine
20 mg
Group difference
test
Age (years) 22.9 (4.2) 22.7 (4.8) 22.4 (3.9) F(2,63)<1, NS
Years of
education
15.0 (1.8) 15.9 (2.5) 15.1 (1.4) F(2,63)=1.4, NS
Gender 12 Male, 13 Female 7 Male, 11 Female 11 Male, 12 Female Fisher’s Exact<1,
NS
Body Mass Index
(Kg/m2)
23.2 (2.7) 23.5 (4.8) 24.3 (4.6) F(2,63)<1, NS
Baseline systolic
blood pressure
(mm Hg)
116.2 (10.2) 118.4 (10.8) 122.1 (12.7) F(2,63)=1.67, NS
Baseline diastolic
blood pressure
(mm Hg)
73.7 (7.3) 72.1 (8.7) 74.7 (7.4) F(2,63)<1, NS
Baseline heart
rate (beats/min)
72.0 (11.0) 69.8 (11.9) 73.9 (14.0) F(2,63)<1 NS
Post-test systolic
blood pressure
(mm Hg)
125.1 (15.2) 122.8 (7.3) 136.5 (11.4) F(2,63)=6.1,
p=0.005*@
Post-test diastolic
blood pressure
(mm Hg)
73.8 (13.0) 74.9 (8.1) 83.7 (8.4) F(2,63)=5.0,
p=0.01*@
Post-test heart
rate (beats/min)
62.8 (8.1) 69.1 (8.4) 75.6 (18.6) F(2,63)=4.1,
p=0.02*
Change systolic 7.3 (14.7) 2.3 (9.9) 13.5 (12.0) F(2,63)=3.0,
p=0.06@
Change diastolic −0.45 (11.2) 0.42 (9.5) 9.2 (9.8) F(2,63)=4.8,
p=0.01*@
*

p< .05, placebo vs. amphetamine 20 mg.

@

p < .05, amphetamine 10 mg vs. amphetamine 20 mg.

F F-statistic, NS not significant